Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Advicenne Granted Reimbursement for Likozam® in France and Sees Thereby Its Debt Reduced by Nearly €6 Million

Likozam® will be reimbursed to patients starting June 12, 2026

Official reimbursement ends the “Early Access” clawback

The price obtained offsets the discounts owed under the early access program and reduces the debt owed to the French government by nearly €6 million

Regulatory News: